Funding in Focus

Funding in Focus: Everyone will become a software engineer and fighting the world's biggest health problems.

Will we get obesity under control and make cancer less frightening? And will software engineers still have a promissing future? Read about what Poolside, Kailera Therapeutics, and Aktis Oncology are up to.

Tom Tholen

Oct 6, 2024 — 4 min read

Tom here! 👋 You’re reading Funding in Focus —my newsletter where we bring into focus some of the most notable VC deals that happened last week.

The top 3 of the deals that happened last week are:

Poolside, $500m series B (led by Bain Capital Ventures)
Kailera Therapeutics, $400m series A (led by RTW Investments, Atlas Ventures, Bain Capital Life Sciences)
Aktis Oncology, $175m series B (led by RTW Investments, Janus Henderson Investors, RA Capital Management)

So let's dive deeper what these companies are up to.

Funding in Focus: Large-scale long-duration electricity storage.

Can we run the electricity grid reliably and affordably while increasing the share of less consistent renewable energy sources?

Funding in Focus: Twelve - A fossil-free future through the science of carbon transformation.

This week I focus on Twelve that secured $645 million in funding. Twelve's mission is: "To eliminate global emissions and build a fossil-free future by transforming CO2 into essential products through the power of electrochemistry."

Read more

Funding in Focus: Large-scale long-duration electricity storage.

Funding in Focus: Twelve - A fossil-free future through the science of carbon transformation.